Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial

Arlene Chan, Beverly Moy, Janine Mansi, Bent Ejlertsen, Frankie A. Holmes, Stephen Chia, Hiroji Iwata, Michael Gnant, Sibylle Loibl, Carlos H. Barrios, Işıl Somali, Snezhana Smichkoska, Noelia Martínez-Jáñez, Mirta Garcia Alonso, John S. Link, Ingrid A. Mayer, Søren Cold, Serafin Morales Murillo, Francis M. Senecal, Kenichi Inoue, Manuel Ruíz‐Borrego, Rina Hui, Neelima Denduluri, Debra A. Patt, Hope S. Rugo, Stephen Johnston, Richard Bryce, Bo Zhang, Feng Xu, Alvin Wong, Miguel Martín